Oral iron replacement vs. IV iron treatment in bariatric surgery patients with anemia

JAAPA. 2023 Apr 1;36(4):1-6. doi: 10.1097/01.JAA.0000911240.72750.c3.

Abstract

Bariatric surgery has become a recognized tool to reduce weight and resolve or improve comorbid conditions associated with obesity. Patients with obesity are at risk for nutritional deficiencies because of poor-quality diets and the chronic inflammatory state of obesity. Iron deficiency is common in these patients, with incidence rates as high as 21.5% preoperatively and 49% postoperatively. Iron deficiency is often overlooked and not treated, leading to increased complications. This article reviews the risk factors for developing iron-deficiency anemia, diagnosis, and treatment considerations for oral versus IV iron replacement for patients undergoing bariatric surgery.

Publication types

  • Review

MeSH terms

  • Anemia* / drug therapy
  • Anemia* / etiology
  • Anemia, Iron-Deficiency* / drug therapy
  • Anemia, Iron-Deficiency* / etiology
  • Bariatric Surgery* / adverse effects
  • Humans
  • Iron / therapeutic use
  • Iron Deficiencies*
  • Obesity / complications

Substances

  • ferryl iron
  • Iron